- Home
- SWX vs PTGX Comparison
SWX vs PTGX Comparison
Compare SWX & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWX
- PTGX
- Stock Information
- Founded
- SWX 1931
- PTGX 2006
- Country
- SWX United States
- PTGX United States
- Employees
- SWX N/A
- PTGX N/A
- Industry
- SWX Oil & Gas Production
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- SWX Utilities
- PTGX Health Care
- Exchange
- SWX Nasdaq
- PTGX Nasdaq
- Market Cap
- SWX 5.6B
- PTGX 5.0B
- IPO Year
- SWX N/A
- PTGX 2016
- Fundamental
- Price
- SWX $79.48
- PTGX $84.49
- Analyst Decision
- SWX Strong Buy
- PTGX Strong Buy
- Analyst Count
- SWX 4
- PTGX 9
- Target Price
- SWX $84.50
- PTGX $86.44
- AVG Volume (30 Days)
- SWX 369.9K
- PTGX 887.0K
- Earning Date
- SWX 11-05-2025
- PTGX 11-06-2025
- Dividend Yield
- SWX 3.12%
- PTGX N/A
- EPS Growth
- SWX 157.10
- PTGX N/A
- EPS
- SWX 6.42
- PTGX 0.72
- Revenue
- SWX $4,649,933,000.00
- PTGX $209,217,000.00
- Revenue This Year
- SWX N/A
- PTGX N/A
- Revenue Next Year
- SWX N/A
- PTGX $140.23
- P/E Ratio
- SWX $12.38
- PTGX $117.62
- Revenue Growth
- SWX 41.35
- PTGX N/A
- 52 Week Low
- SWX $64.69
- PTGX $33.31
- 52 Week High
- SWX $82.51
- PTGX $93.25
- Technical
- Relative Strength Index (RSI)
- SWX 47.82
- PTGX 64.48
- Support Level
- SWX $78.52
- PTGX $82.06
- Resistance Level
- SWX $82.00
- PTGX $86.90
- Average True Range (ATR)
- SWX 1.81
- PTGX 3.11
- MACD
- SWX -0.10
- PTGX 0.14
- Stochastic Oscillator
- SWX 47.63
- PTGX 77.23
About SWX Southwest Gas Holdings Inc. (DE)
Southwest Gas Holdings Inc is a utility company engaged in the purchasing, distributing, and transporting of natural gas in the American Southwest. The company segments its activities into natural gas distribution and Utility Infrastructure Services units. The first of these encompasses the company's core natural gas business as distributors in the states of Arizona and Nevada. The natural gas distribution division is responsible for roughly half of Southwest Gas' total revenue through the sale of natural gas to mainly residential and small commercial customers. The Utility Infrastructure Services segment generates the other half of the company's total revenue from the underground piping contractor services that its subsidiary, Centuri Construction Group, provides.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.